Paul A. Pham

2.1k total citations
38 papers, 1.5k citations indexed

About

Paul A. Pham is a scholar working on Infectious Diseases, Epidemiology and Emergency Medicine. According to data from OpenAlex, Paul A. Pham has authored 38 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 30 papers in Infectious Diseases, 10 papers in Epidemiology and 10 papers in Emergency Medicine. Recurrent topics in Paul A. Pham's work include HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (10 papers) and HIV-related health complications and treatments (10 papers). Paul A. Pham is often cited by papers focused on HIV/AIDS drug development and treatment (26 papers), HIV/AIDS Research and Interventions (10 papers) and HIV-related health complications and treatments (10 papers). Paul A. Pham collaborates with scholars based in United States, Singapore and United Kingdom. Paul A. Pham's co-authors include Joel E. Gallant, Andrew Stolbach, John G. Bartlett, Asa Margolis, Richard E. Chaisson, Timothy R. Sterling, Charles Flexner, Alice J. Hsu, Anne Spinewine and Olalekan A. Uthman and has published in prestigious journals such as Clinical Infectious Diseases, Journal of Virology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Paul A. Pham

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul A. Pham United States	17	1000	507	457	375	135	38	1.5k
Cristina Gervasoni Italy	22	1.4k 1.4×	601 1.2×	578 1.3×	619 1.7×	156 1.2×	132	2.1k
Paola Meraviglia Italy	19	941 0.9×	556 1.1×	368 0.8×	330 0.9×	113 0.8×	61	1.3k
Markus Bickel Germany	25	1.1k 1.1×	657 1.3×	691 1.5×	638 1.7×	69 0.5×	73	1.9k
Achim Schwenk United Kingdom	25	783 0.8×	344 0.7×	474 1.0×	433 1.2×	68 0.5×	55	1.9k
Ferdinand W N M Wit Netherlands	22	1.4k 1.4×	910 1.8×	550 1.2×	325 0.9×	144 1.1×	43	2.1k
Mark S. Shaefer United States	24	1.5k 1.5×	1.1k 2.1×	419 0.9×	438 1.2×	222 1.6×	79	2.4k
Sara Hughes United Kingdom	11	694 0.7×	329 0.6×	319 0.7×	433 1.2×	250 1.9×	22	2.2k
Prudence Ive South Africa	22	1.7k 1.7×	950 1.9×	702 1.5×	176 0.5×	119 0.9×	48	2.0k
Giuliano Rizzardini Italy	15	800 0.8×	539 1.1×	341 0.7×	286 0.8×	34 0.3×	39	1.3k
Laura Waters United Kingdom	25	1.6k 1.6×	936 1.8×	472 1.0×	798 2.1×	112 0.8×	96	2.2k

Countries citing papers authored by Paul A. Pham

Since Specialization

Citations

This map shows the geographic impact of Paul A. Pham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul A. Pham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul A. Pham more than expected).

Fields of papers citing papers by Paul A. Pham

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul A. Pham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul A. Pham. The network helps show where Paul A. Pham may publish in the future.

Co-authorship network of co-authors of Paul A. Pham

This figure shows the co-authorship network connecting the top 25 collaborators of Paul A. Pham. A scholar is included among the top collaborators of Paul A. Pham based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul A. Pham. Paul A. Pham is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pham, Paul A., et al.. (2021). Infectious Diseases Learning Unit: Understanding Advances in the Treatment of Latent Tuberculosis Infection Among People With Human Immunodeficiency Virus. Open Forum Infectious Diseases. 8(8). ofab319–ofab319. 2 indexed citations

Stolbach, Andrew, et al.. (2015). A Review of the Toxicity of HIV Medications II: Interactions with Drugs and Complementary and Alternative Medicine Products. Journal of Medical Toxicology. 11(3). 326–341. 57 indexed citations

Lucas, Gregory M., Michael J. Ross, Peter G. Stock, et al.. (2014). Executive Summary: Clinical Practice Guideline for the Management of Chronic Kidney Disease in Patients Infected With HIV: 2014 Update by the HIV Medicine Association of the Infectious Diseases Society of America. Clinical Infectious Diseases. 59(9). 1203–1207. 9 indexed citations

Margolis, Asa, et al.. (2013). A Review of the Toxicity of HIV Medications. Journal of Medical Toxicology. 10(1). 26–39. 261 indexed citations

Nachega, Jean B., Alice J. Hsu, Olalekan A. Uthman, Anne Spinewine, & Paul A. Pham. (2012). Antiretroviral therapy adherence and drug–drug interactions in the aging HIV population. AIDS. 26(Supplement S1). S39–S53. 83 indexed citations

Wong, Frances, Alice J. Hsu, Paul A. Pham, et al.. (2012). Antiretroviral Treatment Strategies in Highly Treatment Experienced Perinatally HIV-infected Youth. The Pediatric Infectious Disease Journal. 31(12). 1279–1283. 12 indexed citations

Yehia, Baligh R., et al.. (2012). Antiretroviral Medication Errors Remain High but Are Quickly Corrected Among Hospitalized HIV-Infected Adults. Clinical Infectious Diseases. 55(4). 593–599. 36 indexed citations

Thomas, David L., John G. Bartlett, Marion G. Peters, et al.. (2011). Provisional Guidance on the Use of Hepatitis C Virus Protease Inhibitors for Treatment of Hepatitis C in HIV-Infected Persons. Clinical Infectious Diseases. 54(7). 979–983. 23 indexed citations

Lee, Lawrence, et al.. (2010). Darunavir/ritonavir and efavirenz exert differential effects on MRP1 transporter expression and function in healthy volunteers. Antiviral Therapy. 15(2). 275–279. 8 indexed citations

10.

Pham, Paul A., et al.. (2010). Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B. Expert Review of Anti-infective Therapy. 8(10). 1079–1092. 22 indexed citations

11.

Pham, Paul A. & Charles Flexner. (2010). Emerging antiretroviral drug interactions. Journal of Antimicrobial Chemotherapy. 66(2). 235–239. 24 indexed citations

12.

Sterling, Timothy R., Paul A. Pham, & Richard E. Chaisson. (2010). HIV Infection–Related Tuberculosis: Clinical Manifestations and Treatment. Clinical Infectious Diseases. 50(s3). S223–S230. 106 indexed citations

13.

Pham, Paul A.. (2009). Antiretroviral Adherence and Pharmacokinetics: Review of Their Roles in Sustained Virologic Suppression. AIDS Patient Care and STDs. 23(10). 803–807. 17 indexed citations

14.

Thio, Chloe L., et al.. (2009). Tenofovir for the Treatment of Hepatitis B Virus. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 29(10). 1212–1227. 25 indexed citations

15.

Pham, Paul A.. (2008). Drug–Drug Interaction Programs in Clinical Practice. Clinical Pharmacology & Therapeutics. 83(3). 396–398. 10 indexed citations

16.

Pham, Paul A., Charles Flexner, Teresa L. Parsons, et al.. (2007). Beneficial Pharmacokinetic Interaction Between Atazanavir and Lopinavir/Ritonavir. JAIDS Journal of Acquired Immune Deficiency Syndromes. 45(2). 201–205. 10 indexed citations

17.

Pham, Paul A. & Joel E. Gallant. (2006). Tenofovir disoproxil fumarate for the treatment of HIV infection. Expert Opinion on Drug Metabolism & Toxicology. 2(3). 459–469. 20 indexed citations

18.

Zhang, Haili, Yan Zhou, Daphne Monie, et al.. (2004). Novel Single-Cell-Level Phenotypic Assay for Residual Drug Susceptibility and Reduced Replication Capacity of Drug-Resistant Human Immunodeficiency Virus Type 1. Journal of Virology. 78(4). 1718–1729. 157 indexed citations

19.

Gallant, Joel E. & Paul A. Pham. (2003). Tenofovir disoproxil fumarate (Viread®) for the treatment of HIV infection. Expert Review of Anti-infective Therapy. 1(3). 415–422. 11 indexed citations

20.

Pham, Paul A.. (2001). Caspofungin Acetate. Infectious Diseases in Clinical Practice. 10(5). 282–283. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact